We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Two Tests and Timing Are Important in Q Fever Diagnosis

By LabMedica International staff writers
Posted on 04 Oct 2010
The diagnosis of Q fever requires both an immunoassay and a molecular test to establish a definitive diagnosis and is temporally dependent. More...


Q fever is a zoonotic disease caused by Coxiella burnetii, a species of bacteria that is distributed globally. A diagnosis of Q fever requires serologic testing to detect the presence of antibodies to C. burnetii antigens. In most laboratories, the indirect immunofluorescence assay (IFA) is the most dependable and widely used method.

In a recent study carried out at the University Hospital (Jena, Germany), the serum of 22 patients with acute Q fever, was tested by three different methods fever in reference to the time of serum collection. The serum were tested with a commercially available enzyme-linked immunosorbent assay (ELISA) called BEP III, (Virion-Serion, Wuerzburg, Germany); an indirect fluorescent antibody test (IFAT) (Focus Diagnostics, Cypress, CA, USA). An in-house nested polymerase chain reaction (PCR) was used to amplify the DNA of the organism.

A sensitivity of 30% by ELISA and 80% by IFAT) was found for the first five days of illness and 92% by ELISA and 83% by IFAT during the sixth and eleventh day. PCR revealed a positive result in eight cases (36%) with six cases deriving from the first five days of illness. The authors concluded that ELISA aids especially in the diagnosis of Q fever after five days of illness. The benefit of PCR as an additional tool to ELISA was especially evident in the early days of serum sampling. The detection rate with IFAT within the first five days was higher than the data previously reported, where 50% of the serum samples had Immunoglobulin M (IgM)-positive IFAT titers on day six. A diagnosis with IgM-IFAT could be made in 53% (17/32) of patients during the first week after onset, and in 89% (33/37) during the second week. The results of the study were published in the October 2010, issue of Diagnostic Microbiology and Infectious Disease.

Outbreaks of Q fever are often associated with sheep and goat farms and a large outbreak has been ongoing in the Netherlands since 2007. There have also been recent outbreaks in the UK and Germany, as well as amongst US marines stationed in Iraq.

Related Links:

University Hospital
Virion-Serion
Focus Diagnostics




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.